A multivalent CD44 glycoconjugate vaccine candidate for cancer immunotherapy
Rui Freitas, Andréia Miranda, Dylan Ferreira, Marta Relvas‐Santos, Flávia Castro, Eduardo Ferreira, Cristiana Gaiteiro, Janine Soares, Sofia Cotton, Martina Gonçalves, Mariana Eiras, Beatriz Santos, Carlos Palmeira, Margareta P. Correia, María José Oliveira, Bruno Sarmento, Andreia Peixoto, Lúcio Lara Santos, André M. N. Silva, José Alexandre Ferreira
Topics & Concepts
GlycopeptideCD44GlycoconjugateImmunotherapyGlycanCancerCancer immunotherapyCancer vaccineIn vivoAntibodyCancer researchImmunologyBiologyChemistryMedicineGlycoproteinImmune systemIn vitroBiochemistryInternal medicineAntibioticsBiotechnologyGlycosylation and Glycoproteins ResearchImmunotherapy and Immune ResponsesPeptidase Inhibition and Analysis